For example, loss‐of‐function (LOF) variants and variants of unknown significance (VUS) in the ataxia‐telangiectasia‐mutated (ATM) gene were reported to be enriched in cases with MPM, and the most common nonmelanoma cancers among these patients were BCC followed by prostate cancer.23 This evidence concerns the gene ATM and prostate cancer.